Wednesday, May 3, 2023 Daily Archives

High Precision: Automated Aseptic Filling of Small Volumes

by

Market experts recommend automated filling systems for drug developers seeking to reach the next level in drug-substance management. Many companies are starting automation initiatives, which suggests an overall trend towards automated filling. The stakes are high. Increased process deviation in fluid management can lead to increased loss of valuable biopharmaceutical products. Automated and standardized aliquoting of biopharmaceutical drug substances into single-use bioprocess containers simplifies the manufacturing process while improving throughput, speed, and filling accuracy. Fill out the form below to…

May 3, 2023

Making sensor at Interphex: Hamilton showcases process analytics tech

by

Hamilton Company showcased inline sensors measuring cell density, carbon dioxide, and other bioprocess variables at this year’s Interphex in New York last week. Life sciences firm Hamilton sells inline measurement solutions to biomanufacturers aimed at providing inline measurement to improve biomanufacturers’ process understanding and control. Jacob Crowe, manager of Applications and Tech Support, Process Analytics at Hamilton Company, introduced three of these to BioProcess Insider. “The first is what we call our Incyte Arc. It’s a viable cell density measurement…

May 3, 2023

Astellas forks out $5.9bn to buy Iveric Bio

by

Astellas Pharma will add various ophthalmology treatments through the acquisition of US firm Iveric Bio for $5.9 billion. Iveric (formally known as Ophthotech) focuses on developing solutions for retina diseases and its key asset is avacincaptad pegol (ACP), which is in trials for the treatment of geographic atrophy (GA), a condition that can lead to vision loss.Once the deal closes, New Jersey-based Iveric Bio will become a wholly owned subsidiary of Japan’s Astellas. “Iveric Bio has promising programs including ACP,…

May 3, 2023